ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1987

Renal-Derived Alpha-Defensins 1-3 Contribute to Enhanced Urinary Tract Protection in Humanized Mouse Transplant Model Challenged against Uropathogenic Escherichia coli

Session Information

Category: Pediatric Nephrology

  • 1700 Pediatric Nephrology

Authors

  • Canas, Jorge Jose, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Hooks, Jenaya, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Arregui, Sam W., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Schwaderer, Andrew L., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Hains, David S., Indiana University School of Medicine, Indianapolis, Indiana, United States
Background

Alpha-defensins 1-3 are potent antimicrobial peptides expressed from DEFA1A3 gene locus by human neutrophils and kidneys. Decreased DNA copy numbers of DEFA1A3 have been associated with UTI susceptibility. Here, we utilize a human DEFA1 knock-in transgenic mouse (Defa+) to study the role of DEFA1A3 in UTIs. We hypothesized that DEFA1 protects the murine urinary tract from uropathogenic E. coli (UPEC) challenge and renally derived DEFA1A3 is the protective source.

Methods

Female wild-type (WT) and Defa+ mice were infected by transurethral inoculation of UPEC; CFT073, pyelonephritis strain. Bacterial burdens in kidneys and bladders for each group of mice were analyzed at 6 hours post-infection (hpi). We performed transplant isografts of DefaKidney → WTRecipient mice and used WTKidney → WTRecipient as biological controls for UPEC challenges (Figure 1A).

Results

Murine bladder and kidney CFU bacterial burdens results are presented in Figure 1: Comparing the groups at 6 hpi, CFU burden averages were significantly lower in the DefaKidney → WTRecipient infected bladder group, similarly to infected Defa+ mice when compared to its WT counterpart (B). Strikingly, kidneys from DefaKidney → WTRecipient were protected against bacterial growth, in contrast to WTKidney → WTRecipient controls, which showed higher titers of CFU burdens per transplanted kidney following pyelonephritis challenge, and recapitulates the protective phenotype observed in the Defa+ infected mice when compared to its WT control group (C).

Conclusion

Our findings support the role of renal-derived alpha-defensins 1-3 in not only protecting the transplanted kidney but the entire lower urinary tract from UPEC.

Murine isograft transplant model & CFU bacterial burden results of infected upper and lower urinary tract tissues

Funding

  • NIDDK Support